Latest Revenue Growth News

Vysarn Limited reported a robust 40% increase in revenue to $106.5 million for FY2025, driven by key acquisitions and national expansion. The company’s profit after tax rose 34%, underscoring its growing footprint in Australia’s water infrastructure sector.

BrainChip Holdings reports a significant revenue surge and reduced losses in H1 2025, underpinned by new contracts, strategic collaborations, and an expanded funding agreement.

EVZ Limited reported solid FY2025 results with an 8% increase in revenue to $108 million and a 20% rise in EBITDA, underpinned by operational improvements and a robust contract backlog exceeding $90 million.

EVZ Limited reported a 9% revenue decline to $108 million in FY2025, driven by a slowdown in its Energy and Resources sector, yet achieved an 8% rise in EBITDA reflecting improved profitability. The company’s net profit after tax fell 42%, impacted by tax adjustments, as it pursues margin expansion and growth through acquisitions.

Cryosite Limited reported a 12% increase in revenue for FY25, driven by a 58% surge in its ultra-frozen and cryogenic segment, while deferring dividends to fund expansion plans.

MaxiPARTS Limited reported robust FY25 results with strong revenue growth, improved margins, and significant debt reduction, underpinning a confident outlook despite market challenges.

MaxiPARTS Limited reported a robust FY25 with revenues climbing 9.5% to $267.1 million and net profit soaring 179% to $7.7 million, underpinned by strategic acquisitions and margin improvements.

Wrkr Ltd reported a 10.8% revenue increase to $10.63 million and narrowed its net loss to $2.62 million for FY2025, while securing $15 million in fresh capital to accelerate growth amid upcoming PayDay Super reforms.

FFI Holdings Limited reported a remarkable 283.5% jump in net profit for FY2025, driven by property revaluations and operational growth, while raising $7.2 million to fund expansion in food manufacturing and property development.

Aerometrex has confirmed Robert Veitch as its new CEO and Managing Director, following a strategic overhaul that delivered $2 million in annual cost savings and boosted its MetroMap revenue stream.

Atomo Diagnostics reports a significant expansion in its supply agreement with Lumos for the Pascal test cassette, tied to the promising CLIA waiver status of the FebriDx test in the US. This deal could nearly double Atomo’s revenues over the next three years.

Healius Limited reported a 5.7% rise in FY25 revenue driven by pathology growth, while underlying EBIT fell 27% impacted by cyclone disruptions and restructuring. The company advances its pathology strategy and cost savings post-Lumus divestment.